V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300005183 | 300003520 | 1.6 | 97.4 | Not known (9) | 2017-06-01 | 2017-06-07 | Dacarbazine | 2 | null | 300019084 | OXALIPLATIN + MDG |
| 300005184 | 300003521 | 1.81 | null | Disease modification (D) | 2013-07-15 | 2013-08-10 | CAP + RT | N | N | 300019303 | CAPECITABINE + OXALIPLATIN |
| 300005185 | 300003521 | 1.8 | null | Curative (C) | 2016-08-09 | 2016-08-22 | Gemcitabine + Capecitabine | 02 | N | 300019303 | CETUXIMAB + CISPLATIN + FU |
| 300005186 | 300003522 | null | 97.7 | Palliative (P) | 2018-06-22 | 2018-06-29 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 300019648 | TCF |
| 300005187 | 300003523 | 1.69 | 70.4 | Palliative (P) | 2016-04-16 | 2016-04-25 | Folfirinox | Y | N | 300019664 | ESPAC TRIAL |
| 300005188 | 300003524 | 1.51 | 83.1 | Not known (9) | 2015-09-20 | 2015-09-20 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | 300019861 | BEVACIZUMAB + IRINOTECAN + MDG |
| 300005189 | 300003524 | 1.7 | 62.5 | Curative (C) | 2016-06-14 | 2016-07-08 | FLUOROURACIL + MITOMYCIN | 02 | null | 300019861 | FLUOROURACIL + MITOMYCIN + RT |
| 300005190 | 300003525 | 1.6 | 72 | Not known (9) | 2016-09-29 | 2016-10-13 | FEC 100 + DOCETAXEL | N | N | 300019952 | CARBO + FLUOROURACIL |
| 300005191 | 300003526 | 1.69 | 54 | Palliative (P) | null | 2016-11-04 | Dacarbazine | N | N | 300019981 | NOT MATCHED |
| 300005192 | 300003527 | 1.71 | 100 | null | null | 2015-09-05 | Capecitabine + Cisplatin | null | null | 300020166 | CAPECITABINE + OXALIPLATIN |
| 300005193 | 300003527 | 1.57 | 80 | Palliative (P) | 2015-05-03 | 2015-05-24 | Paclitaxel 7 day | N | N | 300020166 | CAPECITABINE + CISPLATIN |
| 300005194 | 300003528 | 1.5 | 60.4 | Palliative (P) | 2016-06-03 | 2016-06-03 | Gemcitabine + Capecitabine | 02 | null | 300020519 | FLUOROURACIL + MITOMYCIN + RT |
| 300005195 | 300006322 | null | null | Palliative (P) | null | 2016-06-18 | Carboplatin + Etoposide IV 3 day | N | null | 300020888 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005196 | 300003529 | null | null | Palliative (P) | 2015-08-14 | 2015-08-21 | ESPAC-4 TRIAL | 99 | Y | 300020983 | GEMCARBO |
| 300005197 | 300003530 | 1.61 | 63 | Curative (C) | 2016-05-23 | 2016-05-28 | Carboplatin AUC 2 - 5 | 2 | N | 300021093 | BENDAMUSTINE + RITUXIMAB |
| 300005198 | 300003530 | 1.68 | 85.45 | Adjuvant (A) | 2018-10-06 | 2018-10-11 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | null | 300021093 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300005199 | 300003531 | 1.5 | 64.5 | Palliative (P) | 2018-03-04 | 2018-03-17 | Carboplatin + Liposomal Doxorubicin | Y | N | 300021358 | GEMCARBO |
| 300005200 | 300006324 | 1.6 | null | Palliative (P) | 2017-04-19 | 2017-04-22 | EOX | null | N | 300021431 | OXALIPLATIN + MDG |
| 300005201 | 300006324 | 1.59 | 69 | null | 2014-01-12 | 2014-01-17 | FEC + DOCETAXEL | N | N | 300021431 | ESPAC TRIAL |
| 300005202 | 300008015 | 1.5 | 81.8 | Palliative (P) | null | 2017-05-04 | Oxaliplatin + Modified de Gramont | N | N | 300021642 | GEMCARBO |
| 300005203 | 300008015 | 0 | 92 | Adjuvant (A) | 2014-05-11 | 2014-05-16 | CARBOPLATIN | 01 | N | 300021642 | GEMCARBO |
| 300005204 | 300003532 | 1.74 | 45.2 | Palliative (P) | 2018-05-21 | 2018-05-21 | Bevacizumab 7.5mg/kg | N | N | 300021811 | BEVACIZUMAB |
| 300005205 | 300003532 | null | null | Curative (C) | 2014-10-08 | 2014-10-18 | Oxaliplatin + Modified de Gramont | N | Y | 300021811 | CAPECITABINE + CISPLATIN |
| 300005206 | 300003533 | 1.79 | 68 | Curative (C) | 2015-05-28 | 2015-06-25 | CARBOPLATIN + GEMCITABINE | N | Y | 300021915 | EP |
| 300005207 | 300003533 | 1.68 | 83.1 | Palliative (P) | 2015-12-26 | 2016-01-08 | GemCarbo Days 1+8 | N | N | 300021915 | NOT MATCHED |
| 300005208 | 300003533 | 1.61 | null | Radical (R) | 2015-09-13 | 2015-10-13 | Folfirinox | 02 | null | 300021915 | FLUOROURACIL + MITOMYCIN |
| 300005209 | 300003533 | 1.71 | null | Palliative (P) | 2017-09-30 | 2017-09-30 | DE-ESCALATE TRIAL | 02 | null | 300021915 | ESPAC TRIAL |
| 300005210 | 300003534 | 1.76 | null | Neo-adjuvant (N) | 2017-10-24 | 2017-11-14 | ESPAC-4 TRIAL | N | N | 300021982 | FLUOROURACIL + MITOMYCIN + RT |
| 300005211 | 300003535 | 1.61 | 74.4 | Palliative (P) | 2017-06-05 | 2017-06-26 | CARBOPLATIN + GEMCITABINE | 2 | N | 300022195 | CAPECITABINE + GEMCITABINE |
| 300005212 | 300003535 | 1.77 | 82.4 | Curative (C) | 2018-05-15 | 2017-10-02 | Ipilimumab | N | N | 300022195 | OXALIPLATIN + MDG |
| 300005213 | 300003536 | null | 137 | Curative (C) | 2013-07-12 | 2013-07-28 | Folfirinox | 01 | N | 300022536 | GEMCARBO |
| 300005214 | 300003536 | 1.5 | 57 | Palliative (P) | 2013-05-16 | 2013-06-02 | Oxaliplatin + Modified de Gramont | N | N | 300022536 | OXALIPLATIN + MDG |
| 300005215 | 300003536 | 1.61 | null | Palliative (P) | 2015-07-30 | 2015-07-31 | ESPAC-4 TRIAL | 02 | N | 300022536 | PACLITAXEL |
| 300005216 | 300003536 | 1.6 | null | Palliative (P) | 2015-03-06 | 2015-04-01 | PEMBROLIZUMAB | Y | N | 300022536 | GEMCITABINE + PACLITAXEL |
| 300005217 | 300003537 | null | 95 | Curative (C) | 2013-05-30 | 2013-06-24 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | N | 300023961 | CAPECITABINE + GEMCITABINE |
| 300005218 | 300003537 | 1.74 | 95.5 | null | 2013-07-31 | 2013-08-03 | ECX | 02 | null | 300023961 | FLUOROURACIL |
| 300005219 | 300003538 | null | 65.6 | Curative (C) | 2014-11-02 | 2014-11-02 | ABVD | N | Y | 300024690 | CISPLATIN + FLUOROURACIL + RT |
| 300005220 | 300003539 | null | null | Palliative (P) | 2013-03-19 | 2013-03-20 | ECX | 02 | N | 300024774 | CARBOPLATIN |
| 300005221 | 300003539 | 1.65 | 66.3 | null | 2014-10-09 | 2014-10-19 | Carboplatin AUC 2 - 5 | 02 | null | 300024774 | HYDROXYCARBAMIDE |
| 300005222 | 300003540 | 1.74 | 75.6 | Curative (C) | 2015-05-24 | 2015-06-05 | CARBOPLATIN + RT | 01 | N | 300025022 | CAPECITABINE + CISPLATIN |
| 300005223 | 300003540 | 1.64 | 138 | Palliative (P) | 2016-04-08 | 2016-04-24 | Folfirinox | 2 | N | 300025022 | CAPECITABINE + OXALIPLATIN |
| 300005224 | 300003541 | 1.71 | 82 | Palliative (P) | 2015-02-23 | 2015-02-23 | Capecitabine (21days) + Carboplatin | 02 | N | 300026271 | METHOTREXATE |
| 300005225 | 300006332 | 1.57 | 63.5 | Palliative (P) | 2017-11-24 | 2017-11-26 | FEC 100 | 02 | N | 300026326 | PEMBROLIZUMAB |
| 300005226 | 300007548 | 1.59 | 46.8 | Curative (C) | 2016-10-15 | 2016-11-12 | DAIICHI Trial | Y | Y | 300000053 | GEMCARBO |
| 300005227 | 300003542 | 1.61 | 63.3 | null | 2019-06-08 | 2019-06-08 | Carboplatin + Etoposide iv&po | N | N | 300000539 | CARBOPLATIN + ETOPOSIDE |
| 300005228 | 300003543 | 1.55 | 46.4 | Neo-adjuvant (N) | 2018-01-20 | 2018-01-27 | Oxaliplatin + Modified de Gramont | N | N | 300001292 | CARBOPLATIN + ETOPOSIDE |
| 300005229 | 300003544 | 1.64 | 59.4 | Adjuvant (A) | 2017-10-02 | 2017-10-12 | PACLITAXEL | N | Y | 300001838 | OXALIPLATIN + MDG |
| 300005230 | 300003545 | 1.73 | 129.8 | Palliative (P) | 2016-08-16 | 2016-08-22 | ABC-08 Trial | N | N | 300002733 | CAPECITABINE + OXALIPLATIN |
| 300005231 | 300003546 | 1.74 | 108.5 | Palliative (P) | 2019-03-01 | 2019-03-14 | Gemcitabine + Capecitabine | N | N | 300003315 | CAPECITABINE + CISPLATIN |
| 300005232 | 300003547 | 1.59 | 57.5 | Palliative (P) | 2017-02-03 | 2017-02-17 | IMATINIB | N | N | 300004450 | PACLITAXEL |